Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Adamo

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|May 23, 2014
Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine productionTimm Fiebig, Friedrich Freiberger, Vittoria Pinto, et al.
Journal of Bacteriology|November 24, 2012
Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficileTanja Ðapa, Tanja Dapa, Rosanna Leuzzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2020
Structure of a protective epitope reveals the importance of acetylation of <i>Neisseria meningitidis</i> serogroup A capsular polysaccharidePedro Henriques, Lucia Dello Iacono, Ana Gimeno, et al.
Angewandte Chemie (International Ed. in English)|October 3, 2017
Oxetane Grafts Installed Site-Selectively on Native Disulfides to Enhance Protein Stability and Activity In VivoNuria Martínez-Sáez, Shuang Sun, Davide Oldrini, et al.
Nanomedicine (London, England)|May 29, 2012
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccineDodi Safari, Marco Marradi, Fabrizio Chiodo, et al.
Chemical Science|March 5, 2025
Multimeric, multivalent fusion carrier proteins for site-selective glycoconjugate vaccines simultaneously targeting <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>Charlotte Sorieul, Bartal Mikladal, Dung-Yeh Wu, et al.
ACS Chemical Biology|February 27, 2018
Combined Chemical Synthesis and Tailored Enzymatic Elongation Provide Fully Synthetic and Conjugation-Ready Neisseria meningitidis Serogroup X Vaccine AntigensDavide Oldrini, Timm Fiebig, Maria Rosaria Romano, et al.
Glycoconjugate Journal|September 27, 2014
Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal diseaseRoberto Adamo, Alberto Nilo, Carole Harfouche, et al.
Infection and Immunity|August 6, 2008
Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14Dodi Safari, Huberta A T Dekker, John A F Joosten, et al.
Carbohydrate Polymers|April 19, 2026
Immune responses to glycoconjugate vaccines rely on a balance between polysaccharide length and glycosylation densityFilippo Carboni, Nicoletta Bechi, Daniela Proietti, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|May 23, 2014
Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine productionTimm Fiebig, Friedrich Freiberger, Vittoria Pinto, et al.
Journal of Bacteriology|November 24, 2012
Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficileTanja Ðapa, Tanja Dapa, Rosanna Leuzzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2020
Structure of a protective epitope reveals the importance of acetylation of <i>Neisseria meningitidis</i> serogroup A capsular polysaccharidePedro Henriques, Lucia Dello Iacono, Ana Gimeno, et al.
Angewandte Chemie (International Ed. in English)|October 3, 2017
Oxetane Grafts Installed Site-Selectively on Native Disulfides to Enhance Protein Stability and Activity In VivoNuria Martínez-Sáez, Shuang Sun, Davide Oldrini, et al.
Nanomedicine (London, England)|May 29, 2012
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccineDodi Safari, Marco Marradi, Fabrizio Chiodo, et al.
Chemical Science|March 5, 2025
Multimeric, multivalent fusion carrier proteins for site-selective glycoconjugate vaccines simultaneously targeting <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>Charlotte Sorieul, Bartal Mikladal, Dung-Yeh Wu, et al.
ACS Chemical Biology|February 27, 2018
Combined Chemical Synthesis and Tailored Enzymatic Elongation Provide Fully Synthetic and Conjugation-Ready Neisseria meningitidis Serogroup X Vaccine AntigensDavide Oldrini, Timm Fiebig, Maria Rosaria Romano, et al.
Glycoconjugate Journal|September 27, 2014
Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal diseaseRoberto Adamo, Alberto Nilo, Carole Harfouche, et al.
Infection and Immunity|August 6, 2008
Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14Dodi Safari, Huberta A T Dekker, John A F Joosten, et al.
Carbohydrate Polymers|April 19, 2026
Immune responses to glycoconjugate vaccines rely on a balance between polysaccharide length and glycosylation densityFilippo Carboni, Nicoletta Bechi, Daniela Proietti, et al.
Pageof 10